Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines

References

• Abubakar I, Pimpin L, Ariti C, Beynon R, Mangtani P, Sterne JA, Fine PE, Smith PG, Lipman M, Elliman D, et al. Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis. Health Technol Assessment (Winchester, England) 2013; 17:1-372, v-vi.
   PubMed Web of Science ®Google Scholar
• Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG against tuberculosis: a systematic review of randomised controlled trials. Clin Infect Dis 2014; 58(4):470-80; PMID:24336911; http://dx.doi.org/10.1093/cid/cit790
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Report. 2015. Geneva, Switzerland, 2015. http://www.who.int/tb/publications/global_report/en/ Accessed: 30th January 2016.
   Google Scholar
• Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013; 34:271-86; PMID:23244049; http://dx.doi.org/10.1146/annurev-publhealth-031912-114431
   PubMed Web of Science ®Google Scholar
• World Health Organization. The End TB Strategy. World Health Organization, 2015. http://www.who.int/tb/post2015_strategy/en/ Accessed: 30th January 2016.
   Google Scholar
• Centre for Reviews and Dissemination. CRD's guidance for undertaking reviews in health care. https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf Accessed: 1st December 2015.
   Google Scholar
• Harris RC, White RG, Sumner T, Knight GM. Systematic review of models exploring the epidemiological impact of novel TB vaccines. PROSPERO 2016: CRD42016033266 http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016033266 Accessed: 19th January 2016.
   Google Scholar
• Fone D, Hollinghurst S, Temple M, Round A, Lester N, Weightman A, Roberts K, Coyle E, Bevan G, Palmer S. Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health 2003; 25:325-35; http://dx.doi.org/10.1093/pubmed/fdg075
   Web of Science ®Google Scholar
• Jaime Caro J, Eddy DM, Kan H, Kaltz C, Patel B, Eldessouki R, Briggs AH. Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report. Value in Health 2014; 17:174-82; PMID:24636375; http://dx.doi.org/10.1016/j.jval.2014.01.003
   PubMed Web of Science ®Google Scholar
• ReVelle CS, Lynn WR, Feldmann F. Mathematical models for the economic allocation of tuberculosis control activities in developing nations. Am Rev Respirat Dis 1967; 96:893-909; PMID:6059199
   PubMed Web of Science ®Google Scholar
• Castillo-Chavez C, Feng Z. Global stability of an age-structure model for TB and its applications to optimal vaccination strategies. Math Biosci 1998; 151:135-54; PMID:9711046; http://dx.doi.org/10.1016/S0025-5564(98)10016-0
   PubMed Web of Science ®Google Scholar
• Murray CJ, Salomon JA. Modeling the impact of global tuberculosis control strategies. Proc Natl Acad Sci U S A 1998; 95:13881-6.
   Google Scholar
• Bhunu CP, Garira W, Mukandavire Z, Magombedze G. Modelling the effects of pre-exposure and post-exposure vaccines in tuberculosis control. J Theoret Biolo 2008; 254:633-49; PMID:18644386; http://dx.doi.org/10.1016/j.jtbi.2008.06.023
   PubMed Web of Science ®Google Scholar
• Cohen T, Colijn C, Murray M. Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines. Proc Natl Acad Sci U S A 2008; 105:16302-7.
   PubMed Web of Science ®Google Scholar
• Ditkowsky JB, Schwartzman K. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa–implications for clinical trials: a decision analysis. PloS one 2014; 9:e83526; PMID:24454706; http://dx.doi.org/10.1371/journal.pone.0083526
   PubMed Web of Science ®Google Scholar
• Dye C, Williams BG. Eliminating human tuberculosis in the twenty-first century. J R Soc Interface 2008; 5:653-62; PMID:17690054; http://dx.doi.org/10.1098/rsif.2007.1138
   PubMed Web of Science ®Google Scholar
• Gomes MGM, Franco AO, Gomes MC, Medley GF. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy. Proc R Soc B: Biol Sci 2004; 271:617-23; http://dx.doi.org/10.1098/rspb.2003.2606
   PubMed Web of Science ®Google Scholar
• Rodrigues P, Margheri A, Rebelo C, Gomes MG. Heterogeneity in susceptibility to infection can explain high reinfection rates. J Theoret Biolo 2009; 259:280-90; PMID:19306886; http://dx.doi.org/10.1016/j.jtbi.2009.03.013
   PubMed Web of Science ®Google Scholar
• Young D, Dye C. The development and impact of tuberculosis vaccines. Cell 2006; 124:683-7; PMID:16497578; http://dx.doi.org/10.1016/j.cell.2006.02.013
   PubMed Web of Science ®Google Scholar
• Ziv E, Daley CL, Blower S. Potential public health impact of new tuberculosis vaccines. Emer Infect Dis 2004; 10:1529-35; PMID:15498152; http://dx.doi.org/10.3201/eid1009.030921
   PubMed Web of Science ®Google Scholar
• Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini Jr IM, Dye C, Halloran ME. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 2009; 106:13980-5; PMID:19666590; http://dx.doi.org/10.1073/pnas.0901720106
   PubMed Web of Science ®Google Scholar
• Channing L, Sinanovic E. Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa. Cost Effect Resource Allocation 2014; 12:1-9; PMID:24405884; http://dx.doi.org/10.1186/1478-7547-12-20
   PubMed Web of Science ®Google Scholar
• Dye C. Tuberculosis 2000-2010: control, but not elimination [The Comstock Lecture]. Int J Tuberculosis Lung Dis 2000; 4:S146-S52.
   PubMed Web of Science ®Google Scholar
• Dye C. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered. J R Soc Interface 2013; 10:20130365; PMID:23904584; http://dx.doi.org/10.1098/rsif.2013.0365
   PubMed Web of Science ®Google Scholar
• Gabriela MGM, Rodrigues P, Hilker FM, Mantilla-Beniers NB, Muehlen M, Cristina Paulo A, Medley GF. Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions. J Theoret Biolo 2007; 248:608-17; PMID:17669435; http://dx.doi.org/10.1016/j.jtbi.2007.06.005
   PubMed Web of Science ®Google Scholar
• Hawn TR, Day TA, Scriba TJ, Hatherill M, Hanekom WA, Evans TG, Churchyard GJ, Kublin JG, Bekker LG, Self SG. Tuberculosis vaccines and prevention of infection. Microbiol Mol Biol Rev 2014; 78:650-71; PMID:25428938; http://dx.doi.org/10.1128/MMBR.00021-14
   PubMed Web of Science ®Google Scholar
• Knight GM, Griffiths UK, Sumner T, Laurence YV, Gheorghe A, Vassall A, Glaziou P, White RG. Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries. Proc Natl Acad Sci U S A 2014; 111:15520-5; PMID:25288770; http://dx.doi.org/10.1073/pnas.1404386111
   PubMed Web of Science ®Google Scholar
• Lietman T, Blower SM. Potential impact of tuberculosis vaccines as epidemic control agents. Clin Infect Dis 2000; 30 Suppl 3:S316-22; PMID:10875909; http://dx.doi.org/10.1086/313881
   PubMedGoogle Scholar
• Pienaar E, Fluitt AM, Whitney SE, Freifeld AG, Viljoen HJ. A model of tuberculosis transmission and intervention strategies in an urban residential area. Computat Biol Chem 2010; 34:86-96; PMID:20381428; http://dx.doi.org/10.1016/j.compbiolchem.2010.03.003
   PubMed Web of Science ®Google Scholar
• Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, Fukui T. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol 2001; 30:380-5; PMID:11369746; http://dx.doi.org/10.1093/ije/30.2.380
   PubMed Web of Science ®Google Scholar
• Tseng CL, Oxlade O, Menzies D, Aspler A, Schwartzman K. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health 2011; 11:55; PMID:21269503; http://dx.doi.org/10.1186/1471-2458-11-55
   PubMed Web of Science ®Google Scholar
• Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, Fukui T. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol 2001; 30:380-5; PMID:11369746; http://dx.doi.org/10.1093/ije/30.2.380
   PubMed Web of Science ®Google Scholar
• Shrestha S, Chatterjee S, Rao KD, Dowdy DW. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. J R Soc Interface 2016; 13(116). pii: 20151016; http://dx.doi.org/10.1098/rsif.2015.1016
   Google Scholar
• Harris R, Sumner T, Knight GM, White R. Future trends in TB epidemiology in China and the potential impact of novel age-targeted TB vaccines: A modelling study (SOA-620-06). 46th Union World Conference on Lung Health. Cape Town, South Africa, 2015.
   Google Scholar
• Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Jr., Dye C, Halloran ME. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 2009; 106:13980-5.
   PubMed Web of Science ®Google Scholar
• Trajman A, Steffen RE, Menzies D. Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence. Pulmonary Medicine 2013; 2013:11.
   Google Scholar